RxClay™ (Hydrated Calcium Aluminosilicate) is a montmorillonite class of clay that adsorbs bacterial toxins, inflammatory cytokines, and metabolic toxins in the gastrointestinal tract, resulting in improvement of stool quality.

A clinical trial in canine cancer patients who developed diarrhea as a side-effect of receiving chemotherapy found significant improvement following the oral administration of RxClay™ when first-tier therapeutics for diarrhea failed to improve stool quality.

RxClay™ is free of heavy metal contamination, contains no available aluminum, is sterilized and ground to 60 micron particle size for improved dispersion and more rapid onset of action.